Caryn L. Elsegood

860 total citations
30 papers, 692 citations indexed

About

Caryn L. Elsegood is a scholar working on Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Caryn L. Elsegood has authored 30 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Caryn L. Elsegood's work include Liver physiology and pathology (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Caryn L. Elsegood is often cited by papers focused on Liver physiology and pathology (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Caryn L. Elsegood collaborates with scholars based in Australia, United Kingdom and United States. Caryn L. Elsegood's co-authors include John Mamo, John A. Hamilton, Glen M. Scholz, Paul Masendycz, John K. Olynyk, Amanda Turner, Hang Thuy Dinh, Janina E. E. Tirnitz‐Parker, George C. Yeoh and Ruth Ganß and has published in prestigious journals such as The Journal of Immunology, Hepatology and Biochemistry.

In The Last Decade

Caryn L. Elsegood

30 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caryn L. Elsegood Australia 16 227 203 161 140 130 30 692
Jheem D. Medh United States 16 322 1.4× 83 0.4× 176 1.1× 180 1.3× 198 1.5× 29 846
Masakazu Yasumaru Japan 16 161 0.7× 117 0.6× 103 0.6× 98 0.7× 201 1.5× 31 728
Aastha Jindal Italy 5 203 0.9× 108 0.5× 336 2.1× 173 1.2× 57 0.4× 8 627
John Brooling United States 11 257 1.1× 124 0.6× 495 3.1× 362 2.6× 223 1.7× 15 926
Morgane Baron France 9 422 1.9× 264 1.3× 484 3.0× 112 0.8× 159 1.2× 16 986
Eszter Trojnár United States 11 164 0.7× 160 0.8× 234 1.5× 142 1.0× 118 0.9× 16 647
Xiaodong Peng China 18 410 1.8× 182 0.9× 84 0.5× 44 0.3× 74 0.6× 49 873
Romain Désert United States 14 287 1.3× 82 0.4× 209 1.3× 168 1.2× 95 0.7× 28 694
Yasushi Takii Japan 14 123 0.5× 79 0.4× 331 2.1× 287 2.0× 192 1.5× 18 691

Countries citing papers authored by Caryn L. Elsegood

Since Specialization
Citations

This map shows the geographic impact of Caryn L. Elsegood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caryn L. Elsegood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caryn L. Elsegood more than expected).

Fields of papers citing papers by Caryn L. Elsegood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caryn L. Elsegood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caryn L. Elsegood. The network helps show where Caryn L. Elsegood may publish in the future.

Co-authorship network of co-authors of Caryn L. Elsegood

This figure shows the co-authorship network connecting the top 25 collaborators of Caryn L. Elsegood. A scholar is included among the top collaborators of Caryn L. Elsegood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caryn L. Elsegood. Caryn L. Elsegood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gogoi-Tiwari, Jully, Corey Giles, Dirk Schmidt‐Arras, et al.. (2017). The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury. Journal of Visualized Experiments. 12 indexed citations
3.
Dwyer, Benjamin J., Candice Alexandra Grzelak, Gregory Miller, et al.. (2016). Divergent Inflammatory, Fibrogenic, and Liver Progenitor Cell Dynamics in Two Common Mouse Models of Chronic Liver Injury. American Journal Of Pathology. 186(7). 1762–1774. 26 indexed citations
4.
Stewart, Scott G., Geraldine Kong, Megan Finch‐Edmondson, et al.. (2016). Identification of a thalidomide derivative that selectively targets tumorigenic liver progenitor cells and comparing its effects with lenalidomide and sorafenib. European Journal of Medicinal Chemistry. 120. 275–283. 10 indexed citations
5.
Viebahn, Cornelia S., Volker Benseler, Lauren E. Holz, et al.. (2010). Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. Journal of Hepatology. 53(3). 500–507. 57 indexed citations
6.
Hume, David, et al.. (2009). CD148/DEP-1 association with areas of cytoskeletal organisation in macrophages. Experimental Cell Research. 315(10). 1734–1744. 14 indexed citations
7.
Chang, Margaret Dah-Tsyr, John A. Hamilton, Glen M. Scholz, et al.. (2009). Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake. Cellular Signalling. 21(9). 1361–1369. 28 indexed citations
8.
Cartledge, Kellie, et al.. (2007). Importance of the C-Terminal Domain of Harc for Binding to Hsp70 and Hop as Well as Its Response to Heat Shock. Biochemistry. 46(51). 15144–15152. 4 indexed citations
9.
Elsegood, Caryn L., Ya Zhuo, Gregg Wesolowski, et al.. (2006). M-CSF induces the stable interaction of cFms with αVβ3 integrin in osteoclasts. The International Journal of Biochemistry & Cell Biology. 38(9). 1518–1529. 20 indexed citations
10.
Achuthan, Adrian, Caryn L. Elsegood, Paul Masendycz, John A. Hamilton, & Glen M. Scholz. (2006). CpG DNA enhances macrophage cell spreading by promoting the Src-family kinase-mediated phosphorylation of paxillin. Cellular Signalling. 18(12). 2252–2261. 16 indexed citations
11.
Elsegood, Caryn L. & John Mamo. (2005). An investigation by electron microscopy of chylomicron remnant uptake by human monocyte-derived macrophages. Atherosclerosis. 188(2). 251–259. 12 indexed citations
12.
Elsegood, Caryn L., Sebely Pal, Paul D. Roach, & John Mamo. (2001). Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins. Clinical Science. 101(2). 111–119. 25 indexed citations
13.
Pal, Sebely, Caryn L. Elsegood, Spencer D. Proctor, & John Mamo. (2000). Detection of LDL receptor by ligand blotting with chylomicron remnants labelled with colloidal gold. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 37(4). 471–478. 2 indexed citations
14.
Pal, Sebely, Caryn L. Elsegood, Spencer D. Proctor, & John Mamo. (2000). Detection of LDL Receptor by Ligand Blotting with Chylomicron Remnants Labelled with Colloidal Gold. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 37(4). 471–478. 4 indexed citations
15.
Mamo, John, et al.. (1997). IS ATHEROSCLEROSIS EXCLUSIVELY A POSTPRANDIAL PHENOMENON?. Clinical and Experimental Pharmacology and Physiology. 24(3-4). 288–293. 24 indexed citations
17.
Mamo, John, et al.. (1994). Chylomicron remnant metabolism by macrophages. Atherosclerosis. 109(1-2). 197–198. 3 indexed citations
18.
Mortimer, Bok‐Cheng, et al.. (1993). EFFECTS OF ANAESTHESIA ON THE REMOVAL FROM PLASMA OF INTRAVENOUSLY INJECTED CHYLOMICRON‐LIKE LIPID EMULSIONS IN RATS AND MICE. Clinical and Experimental Pharmacology and Physiology. 20(1). 51–59. 6 indexed citations
19.
Mamo, John, et al.. (1991). Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1081(3). 241–245. 28 indexed citations
20.
Elsegood, Caryn L., et al.. (1991). EFFECTS OF ADRENORECEPTOR ANTAGONISTS AND AGONISTS ON CLEARANCE OF EMULSION MODELS OF TRIACYLGLYCEROL‐RICH LIPOPROTEINS FROM PLASMA IN RATS. Clinical and Experimental Pharmacology and Physiology. 18(11). 775–788. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026